TCAIM
T-cell activation inhibitor, mitochondrial
Also known as: C3orf23, DKFZp313N0621, TCAIM_HUMAN, TOAG-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N3R3
- Gene
- TCAIM
- Ensembl
- ENSG00000179152
- Chromosome
- 3
- Canonical length
- 496 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
496 residues, UniProt reviewed canonical sequence.
>Q8N3R3|TCAIM
1 MFCHLRPMRR LCLEKIFPHW FPFSRALSGA EAVNALRPFY FAVHPDFFGQ HPVEREINEN
61 SLKRLSVYLE NLQKPGFKSL KPTQLTFYVR ETDQSSSDGQ EPFSTSGFRA VKFTLHTRDL
121 LSTVLYILNS CSLSVEHIQS LNTNMHTQPL KEAKRMPDRP IKWDKSYYSF TGFKDPDEDL
181 EQVSRVETTL TSWLDNNGKS AVKKLKNSLP LRKELDRLKD ELSHQLQLSD IRWQRSWGIA
241 HRCSQLHSLS RLAQQNLETL KKAKGCTIIF TDRSGMSAVG HVMLGTMDVH HHWTKLFERL
301 PSYFDLQRRL MILEDQISYL LGGIQVVYIE ELQPVLTLEE YYSLLDVFYN RLLKSRILFH
361 PRSLRGLQMI LNSDRYAPSL HELGHFNIPT LCDPANLQWF ILTKAQQARE NMKRKEELKV
421 IENELIQAST KKFSLEKLYK EPSISSIQMV DCCKRLLEQS LPYLHGMHLC ISHFYSVMQD
481 GDLCIPWNWK NGEAIKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCAIM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- liver: 40 nTPM
- kidney: 23 nTPM
- skeletal muscle: 21 nTPM
- heart muscle: 18 nTPM
- tongue: 18 nTPM
- spinal cord: 14 nTPM
Single-cell type
- distal convoluted tubule cells: 243 nCPM
- myonuclei: 200 nCPM
- choroid plexus epithelial cells: 161 nCPM
- podocytes: 159 nCPM
- loop of henle epithelial cells: 151 nCPM
- renal connecting tubule cells: 151 nCPM
Immune cell
- basophil: 15 nTPM
- eosinophil: 11 nTPM
- myeloid DC: 10 nTPM
- non-classical monocyte: 10 nTPM
- intermediate monocyte: 10 nTPM
- T-reg: 9.4 nTPM
Brain region
- cerebellum: 24 nTPM
- white matter: 21 nTPM
- medulla oblongata: 20 nTPM
- pons: 19 nTPM
- thalamus: 19 nTPM
- midbrain: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.3
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- T-cell activation inhibitor, mitochondrial
- Domain of unknown function DUF4461
- Domain of unknown function DUF4460
- Domain of unknown function (DUF4460)
- Domain of unknown function (DUF4461)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCAIM as an antibody target. Whether an autoantibody or antibody against TCAIM could matter depends on whether native TCAIM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCAIM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCAIM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...